Anti-inflammatory effects of higenamine (Hig) on LPS-activated mouse microglia (BV2) through NF-κB and Nrf2/HO-1

Songwei Yang1, Shifeng Chu2, Qidi Ai3

  • 1Hunan University of Chinese Medicine & Hunan Engineering Technology Center of Standardization and Function of Chinese Herbal Decoction Pieces, Changsha 410208, Hunan, China; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia & Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Insights

Higenamine (Hig) reduces inflammation and oxidative stress in activated microglia by inhibiting the NF-κB pathway and activating the Nrf2/HO-1 pathway, offering potential neuroprotection.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Microglia are crucial brain immune cells implicated in neurological diseases.
  • Microglial activation by inflammatory stimuli like lipopolysaccharide (LPS) drives neuroinflammation and oxidative stress.
  • Higenamine (Hig), a plant alkaloid, shows potential neuroprotective effects, but its mechanisms in activated microglia are unclear.

Purpose of the Study:

  • To investigate the anti-inflammatory and antioxidant effects of Higenamine (Hig) on lipopolysaccharide (LPS)-activated BV2 microglia.
  • To elucidate the underlying molecular mechanisms, focusing on the NF-κB and Nrf2/HO-1 signaling pathways.

Main Methods:

  • BV2 microglia were activated with LPS, and then treated with Higenamine (Hig).
  • Key inflammatory mediators (TNF-α, IL-6, NO, PGE2) and reactive oxygen species (ROS) were quantified.
  • NF-κB pathway activation (p65 translocation, IκBα degradation/phosphorylation) and Nrf2/HO-1 pathway activation were assessed.
  • Specific inhibitors (BAY-11-7082, SnPP) and gene silencing (Nrf2 siRNA) were used to confirm mechanisms.

Main Results:

  • Hig significantly reduced LPS-induced production of TNF-α, IL-6, NO, PGE2, and ROS in BV2 cells.
  • Hig suppressed the NF-κB signaling pathway by inhibiting IκBα degradation and p65 nuclear translocation.
  • Hig promoted the expression of heme oxygenase-1 (HO-1) and nuclear factor erythroid 2-related factor-2 (Nrf2).
  • These effects were partly dependent on Nrf2 activation and mediated via NF-κB inhibition.

Conclusions:

  • Higenamine (Hig) exerts significant anti-inflammatory and antioxidant effects on LPS-activated microglia.
  • The mechanisms involve the inhibition of the NF-κB signaling pathway and the activation of the Nrf2/HO-1 pathway.
  • Hig demonstrates therapeutic potential for neurological diseases associated with microglial activation.